5,346 0.8 Manufacture and sale of medicines, medical supplies and cosmetics segment 82,624 5.1 - - 82,624 100.0 รวม 1,614,607 100 1,637,162 100 (22,555) (1.4) In 2018, Sales and service revenue from the
5,346 0.8 Manufacture and sale of medicines, medical supplies and cosmetics segment 82,624 5.1 - - 82,624 100.0 รวม 1,614,607 100 1,637,162 100 (22,555) (1.4) In 2018, Sales and service revenue from the
192,558 51.7 41,959 21.8 Industry Products 170,016 40.7 179,698 48.3 (9,682) (5.4) Manufacture of skincare products, cosmetics, food supplements and medical used to treat skin disease 13,169 3.2 - - 13,169
343,822 44.0 (19,490) (5.7) Manufacture of skincare products, cosmetics, food supplements and medical used to treat skin disease 24,617 3.0 37,913 4.9 (13,296) (35.1) รวม 829,981 100.0 780,230 100.0 49,751
ศูนย์กลางทางการแพทย์และการส่งออก (Medical Hub) ภายในปี 2563 2) การเจ็บป่วยที่เพ่ิมข้ึนของคนไทยโดยเฉพาะจำนวนผู้ป่วยจากโรคหัวใจ โรคหลอดเลือดสมอง โรคมะเร็ง และโรคเบาหวาน ส่วนหนึ่งเนื่องจากจำนวนประชากรผู้สูงอายุ
medical supply manufacturing and distribution, which increased from the same period of the previous year for 4.80 million baht or 18.99%, resulting in the increase of the Company Group’s gross profit for
COMPANY LIMITED ASIA FIBER PUBLIC COMPANY LIMITED ASIA GREEN ENERGY PUBLIC COMPANY LIMITED ASIA HOTEL PUBLIC COMPANY LIMITED ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY
& medical supplies
Totabl Debt to Equity 0.13 0.25 * based on only cost of medicine & medical supplies
%. The growth was mainly contributed from Property, Plant and Equipment and other assets. PP&E increased due to investment in MRI and Hemodialysis Centers, purchasing Medical Devices and Equipment and